
Jubilant Ingrevia (JUBLINGREA) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
10.3B
Gross Profit
5.1B
49.54%
Operating Income
1.0B
9.84%
Net Income
751.0M
7.30%
EPS (Diluted)
₹4.75
Balance Sheet Metrics
Total Assets
50.3B
Total Liabilities
21.0B
Shareholders Equity
29.3B
Debt to Equity
0.72
Cash Flow Metrics
Operating Cash Flow
773.9M
Free Cash Flow
847.4M
Revenue & Profitability Trend
Jubilant Ingrevia Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 41.2B | 41.0B | 47.4B | 49.1B | 6.8B |
Cost of Goods Sold | 21.1B | 22.5B | 27.0B | 29.6B | 4.0B |
Gross Profit | 20.2B | 18.5B | 20.4B | 19.6B | 2.8B |
Gross Margin % | 48.9% | 45.1% | 43.1% | 39.8% | 40.9% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 914.0M | 564.5M | 516.0M | 65.6M |
Other Operating Expenses | 11.3B | 9.7B | 11.0B | 7.5B | 1.1B |
Total Operating Expenses | 11.3B | 10.6B | 11.6B | 8.0B | 1.1B |
Operating Income | 3.6B | 2.9B | 4.4B | 7.3B | 984.0M |
Operating Margin % | 8.8% | 7.2% | 9.4% | 14.9% | 14.5% |
Non-Operating Items | |||||
Interest Income | - | 10.1M | 12.4M | 12.0M | 5.6M |
Interest Expense | 556.4M | 520.0M | 204.0M | 270.9M | 69.8M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 3.4B | 2.7B | 4.4B | 7.1B | 773.9M |
Income Tax | 924.4M | 847.2M | 1.3B | 2.3B | 230.3M |
Effective Tax Rate % | 26.9% | 31.7% | 29.6% | 32.8% | 29.8% |
Net Income | 2.5B | 1.8B | 3.1B | 4.8B | 543.6M |
Net Margin % | 6.1% | 4.5% | 6.5% | 9.7% | 8.0% |
Key Metrics | |||||
EBITDA | 5.6B | 4.6B | 5.8B | 8.7B | 1.2B |
EPS (Basic) | ₹15.89 | ₹11.56 | ₹19.34 | ₹29.98 | ₹20.78 |
EPS (Diluted) | ₹15.84 | ₹11.55 | ₹19.33 | ₹29.97 | ₹20.78 |
Basic Shares Outstanding | 158067967 | 158168240 | 158971509 | 159029829 | 26165992 |
Diluted Shares Outstanding | 158067967 | 158168240 | 158971509 | 159029829 | 26165992 |
Income Statement Trend
Jubilant Ingrevia Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 693.6M | 787.8M | 727.2M | 376.1M | 733.4M |
Short-term Investments | 832.7M | 41.7M | 125.0M | 188.6M | 497.2M |
Accounts Receivable | 6.1B | 5.7B | 5.1B | 5.8B | 4.7B |
Inventory | 9.4B | 9.4B | 10.4B | 9.1B | 6.1B |
Other Current Assets | 1.5B | 37.8M | 36.8M | 39.5M | 1.6B |
Total Current Assets | 18.5B | 17.8B | 18.2B | 17.6B | 14.2B |
Non-Current Assets | |||||
Property, Plant & Equipment | 25.6B | 14.1M | 16.1M | 16.7M | 17.0M |
Goodwill | 231.8M | 204.3M | 142.0M | 142.2M | 130.2M |
Intangible Assets | 231.8M | 204.3M | 142.0M | 142.2M | 130.2M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 233.8M | 42.4M | 42.4M | 225.9M | 146.6M |
Total Non-Current Assets | 31.8B | 29.5B | 24.4B | 20.3B | 19.5B |
Total Assets | 50.3B | 47.3B | 42.6B | 38.0B | 33.8B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 8.1B | 7.7B | 8.0B | 8.0B | 6.9B |
Short-term Debt | 4.0B | 3.1B | 2.5B | 1.3B | 917.5M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 157.6M | 234.2M | 190.4M | 221.1M | -540.0K |
Total Current Liabilities | 14.0B | 12.9B | 11.8B | 10.5B | 8.9B |
Non-Current Liabilities | |||||
Long-term Debt | 3.7B | 4.3B | 1.6B | 1.1B | 4.6B |
Deferred Tax Liabilities | 2.3B | 2.1B | 1.9B | 1.4B | 278.9M |
Other Non-Current Liabilities | - | - | - | 540.0K | - |
Total Non-Current Liabilities | 7.0B | 7.1B | 4.1B | 3.1B | 5.6B |
Total Liabilities | 21.0B | 19.9B | 15.9B | 13.6B | 14.6B |
Equity | |||||
Common Stock | 158.1M | 158.0M | 159.0M | 159.0M | 159.3M |
Retained Earnings | - | 12.6B | 11.6B | 9.3B | 4.2B |
Treasury Stock | - | 598.6M | 180.9M | 182.3M | 0 |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 29.3B | 27.4B | 26.7B | 24.3B | 19.2B |
Key Metrics | |||||
Total Debt | 7.6B | 7.4B | 4.1B | 2.4B | 5.6B |
Working Capital | 4.5B | 4.9B | 6.4B | 7.1B | 5.3B |
Balance Sheet Composition
Jubilant Ingrevia Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 3.4B | 2.7B | 4.4B | 7.1B | 773.9M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 121.4M | 67.2M | 26.9M | 14.5M | 0 |
Working Capital Changes | -258.0M | 403.2M | -485.0M | -4.1B | -776.9M |
Operating Cash Flow | 3.8B | 3.7B | 4.1B | 3.3B | 194.1M |
Investing Activities | |||||
Capital Expenditures | -3.5B | -5.7B | -4.8B | -2.3B | -275.0M |
Acquisitions | - | 0 | -21.2M | -58.3M | -21.6M |
Investment Purchases | -264.7M | -33.5M | 0 | -58.3M | -139.9M |
Investment Sales | - | 0 | 73.0M | 1.6B | 0 |
Investing Cash Flow | -4.0B | -5.7B | -4.7B | -543.6M | -576.5M |
Financing Activities | |||||
Share Repurchases | 0 | -428.9M | 0 | -182.6M | 0 |
Dividends Paid | -797.7M | -786.2M | -793.1M | -451.6M | - |
Debt Issuance | 270.0M | 3.0B | 1.5B | 0 | - |
Debt Repayment | -244.3M | 0 | -1.0B | -4.5B | -621.9M |
Financing Cash Flow | -518.7M | 2.1B | 883.5M | -3.8B | -621.9M |
Free Cash Flow | 1.4B | -1.4B | -189.2M | 2.2B | 847.4M |
Net Change in Cash | -651.6M | 109.0M | 338.0M | -1.0B | -1.0B |
Cash Flow Trend
Jubilant Ingrevia Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
39.76
Forward P/E
26.09
Price to Book
3.76
Price to Sales
2.63
PEG Ratio
1.06
Profitability Ratios
Profit Margin
6.62%
Operating Margin
9.76%
Return on Equity
8.58%
Return on Assets
4.99%
Financial Health
Current Ratio
1.32
Debt to Equity
26.09
Beta
0.40
Per Share Data
EPS (TTM)
₹17.52
Book Value per Share
₹185.39
Revenue per Share
₹265.21
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
jublingrea | 110.2B | 39.76 | 3.76 | 8.58% | 6.62% | 26.09 |
Asian Paints | 2.4T | 65.80 | 12.24 | 18.28% | 10.63% | 11.42 |
Pidilite Industries | 1.6T | 71.77 | 16.03 | 20.85% | 16.16% | 4.56 |
BASF India | 199.1B | 50.25 | 5.48 | 13.18% | 2.61% | 5.23 |
Atul | 195.2B | 39.07 | 3.49 | 8.55% | 8.71% | 3.56 |
Kansai Nerolac | 188.0B | 16.61 | 2.93 | 17.85% | 14.43% | 4.63 |
Financial data is updated regularly. All figures are in the company's reporting currency.